Elsevier

Human Pathology

Volume 21, Issue 7, July 1990, Pages 759-766
Human Pathology

Original contribution
Malignant epithelioid pleural mesothelioma versus peripheral pulmonary adenocarcinoma: A histochemical, ultrastructural, and immunohistologic study of 103 cases

https://doi.org/10.1016/0046-8177(90)90036-5Get rights and content

Abstract

The distinction between malignant epithelioid pleural mesothelioma (MEPM) and peripheral adenocarcinoma of the lung with pleural invasion (PAL) continues to represent a diagnostic challenge in selected cases. In order to provide comparative data on histologic, histochemical, and immunohistochemical features of these neoplasms, we analyzed 51 ultrastructurally categorized MEPMs and 52 PALs with the periodic acid-Schiff-diastase (PAS-D), mucicarmine, and colloidal iron stains, and a panel of immunohistologic reagents. Antibodies to cytokeratin, vimentin, epithelial membrane antigen (EMA), carcinoembryonic antigen (CEA), Leu M1, the B72.3 antigen, blood group isoantigens (BGI), placental alkaline phosphatase, amylase, S100 protein, and Clara cell antigen were used, as applied to paraffin sections with the avidin-biotin-peroxidase complex technique. Ultrastructural studies revealed long, branching microvilli in MEPM cells in all cases, with length-to-diameter ratios (LDR) or 10:1 or more. In contrast, PAL manifested short, nonbranching microvilli with LDR of 8:1 or less. Reactivity with PAS-D and mucicarmine stains was strictly confined to PAL, and hyaluronidase-sensitive colloidal iron-positivity was restricted to MEPM. However, only 63% and 41% of these respective neoplasms demonstrated such histochemical reactivity. Immunohistologic results correlated well with electron microscopic classification. All MEPMs and PALs were reactive for cytokeratin; in addition, the majority of tumors in each group expressed EMA, and a minority were reactive for vimentin. In adenocarcinomas of the lung, Leu M1 was observed in all cases, CEA was apparent in 96%, B72.3 labeled 84%, and BGI were present in 67%; all PALs expressed at least two of these determinants, but none was seen in any mesothelioma. The other markers included in this study also were observed in some PAL cases, but not in MEPM. These findings suggest that immunohistology parallels electron microscopy in efficacy in the diagnostic separation of MEPM and PAL. Using antibodies to leu M1, CEA, and the B72.3 antigen, reactivity for at least two of these three markers appears to exclude a diagnosis of pleural mesothelioma. The other glycoproteinaceous, oncoplacentofetal, and cytoplasmic antigens we studied can be used to reinforce such a determination, since their distribution is confined to adenocarcinomas.

References (62)

  • M Kannerstein et al.

    Histochemistry in the diagnosis of malignant mesothelioma

    Ann Clin Lab Sci

    (1973)
  • A Dewar et al.

    Pleural mesothelioma of epithelial type and pulmonary adenocarcinoma: An ultrastructural and cytochemical comparison

    J Pathol

    (1987)
  • JG Lucas et al.

    Diagnostic histochemical and immunohistochemical studies in malignant mesothelioma

    J Surg Oncol

    (1987)
  • JC Wagner et al.

    Histochemical demonstration of hyaluronic acid in pleural mesotheliomas

    J Pathol Bacteriol

    (1962)
  • CJ Benjamin et al.

    Histological staining for the diagnosis of mesothelioma

    Am J Med Technol

    (1982)
  • I Dardick et al.

    Diffuse epithelial mesothelioma: A review of the ultrastructural spectrum

    Ultrastruct Pathol

    (1987)
  • MJ Warhol et al.

    Malignant mesotheliomas: Ultrastructural distinction from adenocarcinoma

    Am J Surg Pathol

    (1982)
  • Y Suzuki et al.

    Ultrastructure of human malignant diffuse mesothelioma

    Am J Pathol

    (1976)
  • JW Bolen et al.

    Mesotheliomas: A light and electron microscopical study concerning histogenetic relationships between the epithelial and mesenchymal variants

    Am J Surg Pathol

    (1980)
  • JW Bolen et al.

    Reactive and neuplastic serosal tissue: A light microscopic, ultrastructural, and immunohistochemical study

    Am J Surg Pathol

    (1986)
  • NS Wang

    Electron microscopy in the diagnosis of pleural mesotheliomas

    Cancer

    (1973)
  • NS Wang et al.

    Absence of carcinoembryonic antigen-like material in mesotheliomas: An immunohistochemical differentiation from other lung cancers

    Cancer

    (1979)
  • A Churg

    Immunohistochemical staining for vimentin and keratin in malignant mesothelioma

    Am J Surg Pathol

    (1985)
  • JM Corson et al.

    Mesothelioma: Profile of keratin proteins and carcinoembryonic antigen: An immunoperoxidase study of 20 cases with comparison with pulmonary adenocarcinomas

    Am J Pathol

    (1982)
  • J Holden et al.

    Immunohistochemical staining for keratin and carcinoembryonic antigen in the diagnosis of malignant mesothelioma

    Am J Surg Pathol

    (1984)
  • HJ Kahn et al.

    Distinct keratin patterns demonstrated by immunoperoxidase staining of adenocarcinomas, carcinoids, and mesotheliomas, using polyclonal and monoclonal anti-keratin antibodies

    Am J Clin Pathol

    (1986)
  • AE Walts et al.

    Keratins of different molecular weight in exfoliated mesothelial and adenocarcinoma cells—an aid to cell identification

    Am J Clin Pathol

    (1984)
  • JW Said et al.

    Keratin in human lung tumors: Patterns of localization of different molecular weight keratin proteins

    Am J Pathol

    (1983)
  • A Herbert et al.

    Interpretation of pleural biopsy specimens and aspirates with the immunoperoxidase technique

    Thorax

    (1982)
  • H Battifora et al.

    Distinction of mesothelioma from adenocarcinoma: An immunohistochemical approach

    Cancer

    (1985)
  • WS Kwee et al.

    Histologic distinction between malignant mesothelioma, benign pleural lesion, and carcinoma metastasis

    Virchows Arch [A]

    (1982)
  • Cited by (0)

    Presented at the 77th Annual Meeting of the United States and Canadian Academy of Pathology, Washington, DC, March 1988.

    1

    Dr Wick is currently affiliated with Washington University School of Medicine, St Louis, MO.

    2

    Dr Loy is currently affiliated with the University of Missouri School of Medicine, Columbia, MO.

    View full text